EVC anticorps (N-Term)
Aperçu rapide pour EVC anticorps (N-Term) (ABIN5514747)
Antigène
Voir toutes EVC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- CRAGRQRTRH QKDDTQNLLK NLESNAQTPS ETGSPSRRRK REVQMSKDKE
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human EVC
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EVC (Ellis Van Creveld Syndrome (EVC))
-
Autre désignation
- EVC
-
Sujet
-
This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis.
Alias Symbols: EVC1, EVCL, DWF-1
Protein Size: 992 -
ID gène
- 2121
-
NCBI Accession
- NM_001306090, NP_001293019
-
UniProt
- P57679
-
Pathways
- Signalisation Hedgehog
Antigène
-